Two patients present with pink plaques on different parts of their head and face. Can you correctly identify each case?

Merkel cell carcinoma (MCC) is a rare type of skin cancer ... This operation is called a wide local excision (WLE). The surgeon sends the tissue to the laboratory and a pathologist looks at it under a ...

Introduction: Cutaneous basal cell carcinoma recurrence is associated with inadequate surgical margins. The frequency of and the ... without intraoperative pathological analysis. Prior to excision, ...

Medicus Pharma Ltd. announced promising interim results from its SKNJCT-003 Phase 2 clinical study aimed at the non-invasive treatment of basal cell carcinoma ... in the final excision at the ...

THE LONG-TERM efficacy of superficial curettage (SC) followed by imiquimod cream, 5%, compared with surgical excision (SE) in treating nodular basal cell carcinoma (nBCC) has been evaluated in a ...

Medicus Pharma reports over 50% patient enrollment in Phase 2 study for basal cell carcinoma treatment ... of BCC histologically in the final excision at the end of study visit.

AIMS To evaluate the data for patients with basal cell carcinoma (BCC ... The desired primary skin closure after tumour excision may be achieved by undermining the wound margins if the suture tension ...

The surgical excision group saw a failure rate of 98.2%. Superficial curettage plus imiquimod cream 5% in the treatment of nodular basal cell carcinoma showed more treatment failure at 5 years vs.

Background: Basal cell ... of excision associated with itching and discharge. The discharge was seropurulent. On examination, the patient had a well-defined hyperpigmented ulcer present at the left ...

The following is a summary of “Novel imaging techniques for tumor margin detection in basal cell carcinoma: a systematic scoping review ... and EMA-approved imaging modalities in assessing tumor ...

The 2-part, open-label, multicenter, dose-escalation, proof-of-concept phase 2 study enrolled patients 18 years of age or older with clinically suspected basal cell carcinoma with at least 1 and up to ...

(“Medicus” or the “Company”) announces the enrollment of the first patient in its Phase 2 clinical trial SKNJCT-003 for the treatment of nodular basal cell carcinoma (nBCC). Clinical Trial ...